Unknown

Dataset Information

0

Characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approach.


ABSTRACT: Monoclonal antibodies (mAbs) against human proteins are the primary protein capture reagents for basic research, diagnosis, and molecular therapeutics. The 2 most important attributes of mAbs used in all of these applications are their specificity and avidity. While specificity of a mAb raised against a human protein can be readily defined based on its binding profile on a human proteome microarray, it has been a challenge to determine avidity values for mAbs in a high-throughput and cost-effective fashion. To undertake this challenge, we employed the oblique-incidence reflectivity difference (OIRD) platform to characterize mAbs in a protein microarray format. We first systematically determined the Kon and Koff values of 50 mAbs measured with the OIRD method and deduced the avidity values. Second, we established a multiplexed approach that simultaneously measured avidity values of a mixture of 9 mono-specific mAbs that do not cross-react to the antigens. Third, we demonstrated that avidity values of a group of mAbs could be sequentially determined using a flow-cell device. Finally, we implemented a sequential competition assay that allowed us to bin multiple mAbs that recognize the same antigens. Our study demonstrated that OIRD offers a high-throughput and cost-effective platform for characterization of the binding kinetics of mAbs.

SUBMITTER: Liu S 

PROVIDER: S-EPMC4622085 | biostudies-other | 2015

REPOSITORIES: biostudies-other

altmetric image

Publications

Characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approach.

Liu Shuang S   Zhang Hongyan H   Dai Jun J   Hu Shaohu S   Pino Ignacio I   Eichinger Daniel J DJ   Lyu Huibin H   Zhu Heng H  

mAbs 20150101 1


Monoclonal antibodies (mAbs) against human proteins are the primary protein capture reagents for basic research, diagnosis, and molecular therapeutics. The 2 most important attributes of mAbs used in all of these applications are their specificity and avidity. While specificity of a mAb raised against a human protein can be readily defined based on its binding profile on a human proteome microarray, it has been a challenge to determine avidity values for mAbs in a high-throughput and cost-effect  ...[more]

Similar Datasets

| S-EPMC4000387 | biostudies-other
| S-EPMC5157029 | biostudies-literature
| S-EPMC2917058 | biostudies-literature
| S-EPMC3061328 | biostudies-other
| S-EPMC6981608 | biostudies-literature
| S-EPMC7787445 | biostudies-literature
| PRJEB7720 | ENA
| S-EPMC3776832 | biostudies-literature
| S-EPMC4354037 | biostudies-literature
| S-EPMC7461341 | biostudies-literature